• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconCancer Immunotherapy

Cancer Immunotherapy

A woman in an Allcyte lab coat looking at images of cancer cells on a screen.
TechBritish A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company
By Jeremy KahnJune 15, 2021
Photo of CytoSeek CEO Carolyn Porter
TechNew venture fund backs CytoSeek, a startup looking to give “superpowers” to cancer-fighting T-cells
By Jeremy KahnMarch 16, 2021
Photo of U.S. Speaker of the House Nancy Pelosi wearing a mask and gesturing with her hands.
HealthA Pelosi snub and a giant federal COVID grant: Another dizzying day in Washington for the U.K.’s AstraZeneca
By Jeremy KahnOctober 12, 2020
A sign is seen at an AstraZeneca site in Macclesfield
HealthHere’s Why Shares in This Former Pfizer Target Are Tanking
By Fortune Editors and ReutersJuly 27, 2017
Going to the Wall Against Cancer and Apathy: FDR, Obama, Trump, Laver, and Kyrgios
CommentaryGoing to the Wall Against Cancer and Apathy: FDR, Obama, Trump, Laver, and Kyrgios
By Paul Sanderson and Bethany CiancioloJuly 13, 2017
Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
HealthWhy Shares of Next-Gen Cancer Biotech Juno Rallied Today
By Sy MukherjeeJuly 13, 2016
Stocks Continue Downward Slide On Heels Of Yesterday's Extreme Fall
HealthThis Fund Wants to Make It Easier to Invest in Biotech Stocks
By Sy MukherjeeJune 15, 2016
Bristol Myers Yervoy Cancer Drug
HealthFDA Has Strong Words for Cancer Drug Developers
By ReutersJune 10, 2016
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
HealthMerck CEO: We’re on the Hunt for Deals in 2016
By Sy MukherjeeMay 6, 2016
Napster co-founder, Sean Parker, General
HealthSean Parker Launches an Unprecedented Cancer Research Effort
By Laura LorenzettiApril 13, 2016
1
  • 1
1
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Economy
'People are trying to be creative': Tariff-battered American companies are so cash-starved they are using refund claims as collateral for loansplaceholder alt text
By Fortune EditorsApril 12, 2026
Real Estate
A 93-year-old refused to sell her home to the Masters golf course that’s spent $280 million on expansion: ‘Money ain’t everything’placeholder alt text
By Fortune EditorsApril 12, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.